G PrizeOrder | Quote
2014 Gen9 G-Prize
One million base pairs!
As the Next Gen Gene Synthesis Company, Gen9 has developed an exceptional technology to synthesize DNA constructs using our award winning BioFab® technology. Today, Gen9 is manufacturing and shipping our GeneBit (400bp to 1000bp), GeneByte (1kbp to 4kbp) and GeneByte Plus (4kbp to 10kbp) constructs to customers around the globe.
The G-Prize contest, conceived and exclusively sponsored by Gen9, was launched in 2012 to foster creative and innovative approaches for using synthetic DNA. In previous years the G-Prize contest was only open to academic and nonprofit scientist only. This year, in order to further spark innovation in synthetic biology, two 500,000 base pair prizes will be awarded, one to a pre-commercial startup and one to an academic/public-benefit organization, for a total of 1 million base pairs of synthesized DNA
The winning teams can select to have their DNA sent as any length from 400bp to 10kbp. The submission deadline was midnight EST, 31 December 2014. More about the past G-Prize winners and why we established the G-Prize can be found here. If you have any questions about the contest please email your questions to email@example.com
Thank you and good luck to all those who entered the contest.
Your submission will now move to the judging stage.
The Gen9 G-Prize FAQ
If you don’t see your question below or need more information, please feel free to contact us.
Each winners of the 2014 G-Prize will receive DNA constructs equaling 500,000 base pairs! Each construct is a double-stranded gene fragment from 400 to 10,000 base-pairs in length.
Any scientist from an academic or nonprofit institution or from a start up company may enter. Simply fill out the online application form with a description of how you would use the library of gene constructs. Submissions are due by midnight EST, 31 December 2014.
Two grand prize winners will be chosen (one non-profit & one from a pre-commercial startup company) by the judges to each win 500,000 base pairs.
A panel of judges has been chosen by Gen9 to review the entries and select our winners.
We accept entries from any non-profit or start up organization who has a compelling and constructive use of synthetic biology. All gene sequences submitted will be kept confidential, but we will screen the sequence of every gene submitted by applicants to identify regulated and other potentially dangerous pathogen sequences, and to verify that our entrants are legitimate scientists engaged in beneficial research.